Anzeige
Mehr »
Login
Mittwoch, 02.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 881339 | ISIN: AU000000NUF3 | Ticker-Symbol: NUF
Frankfurt
01.04.25
08:03 Uhr
2,240 Euro
0,000
0,00 %
Branche
Chemie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
NUFARM LIMITED Chart 1 Jahr
5-Tage-Chart
NUFARM LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
2,2602,36008:22
2,2802,36008:22
GlobeNewswire (Europe)
476 Leser
Artikel bewerten:
(2)

Nufarm Partners with KD Nutra on Plant-Based Omega-3 Portfolio Expansion

Finanznachrichten News

WEST SACRAMENTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Nuseed® Nutritional US Inc., the seed technologies platform of Nufarm Limited (ASX: NUF), is partnering with KD Nutra, a division of The KD Pharma Group, to expand offerings of plant-based long-chain omega-3 ingredients. This partnership allows both companies to leverage their expertise to offer the market new sources of omega-3 beyond marine sources and tap into the rapidly growing demand for alternatives.

Nufarm is a global leader in developing agricultural solutions to environmental challenges. Our Omega-3 Canola is the world's first plant-based source of total omega-3 nutrition. Aquaterra® and Nutriterra® are derived from the seed oil and provide alternatives to marine-sourced omega-3 ingredients while delivering all the health benefits that come with this science-backed nutrient.

"Our combined technologies and capabilities have great potential for human health," said Brent Zacharias, Nufarm, Group Executive for Seed Technologies. "KD Nutra's technical expertise and commitment to quality can deliver our plant-based innovations to a broader audience."

"We're excited to partner with Nufarm to expand our plant-based omega-3 offerings," said Kimberly Smith, CEO of KD Nutra. "Nufarm's innovation in plant-based nutrition together with KD Nutra's technology platform and leadership in omega-3 will allow us to bring unique and renewable solutions to the industry."

This research and development partnership will increase access to omega-3 nutrition for the long-term health of people and the planet.

About Nufarm

Nufarm is a global agricultural innovator providing crop protection and seed technology solutions to help our customers grow a better tomorrow. Established over 100 years ago, Nufarm is listed on the Australian Securities Exchange

Nufarm's seed technologies platformand nuseed.com.

About KD Nutra®
KD Nutra® is a technology-driven CDMO with leading expertise in ultra-potent marine-based and algae-based Omega-3 nutritional lipids as well as Specialized Pro-resolving Mediators (SPMs).
As part of the KD Pharma Group, KD Nutra® has become one of the world's largest Omega-3 and fish oil refiners and suppliers.

Our processing systems can manufacture any desired combination of concentration level (up to 99%) and EPA/DHA Omega-3 ratio. Additionally, our kd-pür® supercritical CO2 patented process gently extracts and purifies Omega-3s in a pharmaceutical cGMP-certified facility, without the use of excessive heat, chemical solvents (green technology) or oxygen. Through our unique vertical integration from raw oils to ultra-high potency Omega-3 EPA and DHA concentrates from both vegan and marine sources, we create health solutions for our customers.

Contacts:

Nuseed Nutritional: Katrina Benedicto, Communications Director
+1

Nuseed Global: Rhonda Macdonald, Global Lead, Communications & External Relations
+1

Nufarm Investor Relations: Grant Saligari, +61 406 402 645, grant.saligari@nufarm.com


© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.